1Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of Creactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation,2003,107(8) :1129-1134.
2Tauman R, Ivanenko A, O' Brien LM, et al. Plasma C-reactive protein levels among children with sleep-disordered breathing.Pediatrics, 2004,113 (6): e564-569.
3Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels,sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol, 2000,279 (1): 234-237.
4Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity,insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab,2000,85(3): 1151-1158.
5Ip MS, Lam KS, Ho C, et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 2000,118 (3): 580-586.
6Patel SR, Palmer LJ, Larkin EK, et al. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep, 2004,27(2) :235-239.
7Teramoto S, Kume H, Yamamoto H, et al. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med, 2003,42 (8): 681-685.
8Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea.Sleep,2002,25(1) :59-65.
9Imagawa S, Yamaguchi Y, Ogawa K, et al. Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration, 2004,71 ( 1 ): 24-29.
10Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med,2000,162(6): 2166-2171.
